查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1632986

免疫疗法药物市场：2033 年市场分析与预测 - 按类型、产品、应用、技术、最终用户、流程、模式和阶段

Immunotherapy Drugs Market Analysis and Forecast to 2033: Type, Product, Application, Technology, End User, Process, Mode, Stage
出版日期: | 出版商: Global Insight Services | 英文 361 Pages | 商品交期: 3-5个工作天内

价格
简介目录

免疫疗法市场规模预计将从 2023 年的 1,630 亿美元成长到 2033 年的 3,750 亿美元，复合年增长率为 8.5%。

免疫疗法市场涵盖致力于开发和商业化治疗剂的行业，这些治疗剂利用和增强人体免疫系统来对抗疾病，包括癌症和自体免疫疾病。该市场包括单株抗体、检查点抑制剂、疫苗和细胞疗法，代表着向个人化医疗的范式转变，并为改善患者预后和创新治疗提供了有希望的途径。

市场成长主要得益于癌症治疗和自体免疫疾病管理的进步。单株抗体因其在治疗各种癌症方面的针对性作用和功效而引领市场。检查点抑制剂因其能够激发人体对肿瘤的免疫反应而受到广泛关注，是表现第二好的细分领域。北美地区占据市场主导地位，得益于强大的医疗保健基础设施和大量的研发投资。受政府优惠政策和新疗法日益普及的推动，欧洲紧随其后。在这些地区中，美国和德国表现最佳，反映了他们对创新和获得先进医疗保健解决方案的承诺。亚太地区正在成为一个充满希望的市场，这得益于医疗支出的增加和患者人数的增加，尤其是在中国和印度。这些见解强调了免疫治疗药物市场的动态性质和良好机会。

2023年免疫疗法药物市场呈现强劲成长，市场规模达3.2亿单位。单株抗体领域占最大的市场占有率，为 45%，其次是免疫检查点抑制剂，为 30%，癌症疫苗为 25%。这种分布反映了全球范围内标靶疗法的采用日益增多以及癌症发病率的上升。单株抗体领域尤其受到生物技术和个人化医疗进步的推动。

竞争格局由罗氏、默克和百时美施贵宝等大公司主导，它们各自利用策略伙伴关係和创新研发来提升其市场地位。 FDA 核准和专利法等法规的影响对市场动态有重大影响。未来预测表明，在技术进步和医疗保健支出增加的推动下，到 2033 年其复合年增长率将达到 10%。由于新兴市场的商机及新型免疫疗法药物的开发，市场呈现扩大趋势。然而，课题依然存在，包括治疗成本上升和监管要求更加严格。人工智慧在药物开发中的整合预计将进一步推动成长。

北美主导免疫疗法市场，主要由美国主导。该地区受益于强大的医疗保健基础设施和大量的研发投资。大型製药公司的存在及其对创新的重视进一步增强了市场。该地区慢性病的高发性也推动了对先进治疗方案的需求。

欧洲占免疫疗法药物市场的大部分占有率，其中德国、法国和英国是主要贡献者。该地区完善的医疗保健体系和强大的监管框架支持市场成长。欧洲国家也正在投资个人化医疗，推动免疫疗法药物的采用。该地区也高度重视癌症研究和治疗创新。

亚太地区是一个快速成长的免疫疗法市场。医疗费用的上涨和人们对先进治疗的认识的不断提高促进了这个市场的扩张。中国和印度等国家正在投资医疗保健基础设施和研究项目。这些国家的癌症和其他慢性病发生率不断上升，对有效的免疫疗法治疗的需求日益增长。

拉丁美洲和中东及非洲正逐渐成为免疫治疗药物市场的关键地区。儘管这些地区目前的市场占有率较小，但医疗保健投资的增加和先进医疗治疗机会的改善预计将推动成长。这些地区的政府正致力于改善医疗设施和研发，以支持市场发展。

目录

第 1 章 免疫疗法市场概论

  • 研究目标
  • 免疫疗法市场定义与范围
  • 报告限制
  • 调查年份与货币
  • 研究方法

第 2 章执行摘要

第 3 章 关键市场考量

第 4 章 免疫治疗药物市场展望

  • 免疫疗法市场区隔
  • 市场动态
  • 波特五力分析
  • PESTLE 分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第5章 免疫治疗药物的市场策略

  • 母公司市场分析
  • 供需分析
  • 消费者购买意向
  • 个案研究分析
  • 价格分析
  • 监理状态
  • 供应链分析
  • 竞争产品分析
  • 近期发展

第6章 免疫治疗药物市场规模

  • 免疫治疗药物市场规模（以价值计算）
  • 免疫治疗药物市场规模（以数量计算）

第7章 免疫治疗药物市场按类型划分

    市场概况
  • 单株抗体
  • 检查点抑制剂
  • 细胞因子
  • 癌症疫苗
  • 过继性细胞疗法
  • 溶瘤病毒疗法
  • 其他

第 8 章 免疫疗法市场（依产品）

    市场概况
  • 治疗性疫苗
  • 免疫检查点抑制剂
  • 非特异性免疫治疗药物
  • 癌细胞病毒免疫治疗
  • CAR-T细胞疗法
  • 其他

第 9 章 免疫疗法市场（依应用）

    市场概况
  • 癌症
  • 自体免疫疾病
  • 传染病
  • 发炎性疾病
  • 其他

第 10 章 免疫疗法市场（依技术划分）

    市场概况
  • 基因编辑
  • CRISPR
  • RNA干扰 奈米科技
  • 重组DNA技术
  • 其他
第 11 章 免疫治疗药物市场（依最终使用者）
    市场概况
  • 医院
  • 诊所
  • 研究机构
  • 生物製药公司
  • 其他

第 12 章 免疫治疗药物市场（依流程划分）

    市场概况
  • 製造
  • 研究与开发
  • 临床试验
  • 监理机关核准
  • 启动
  • 其他

第 13 章 免疫治疗药物市场（按模式）

    市场概况
  • 静脉注射
  • 口服
  • 本地
  • 吸入
  • 其他
第 14 章：免疫疗法市场（依阶段）
    市场概况
  • 药物研发
  • 临床前
  • 临床试验
  • 授权
  • 启动
  • 上市后监测
  • 其他

第 15 章 免疫治疗药物市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
    亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非
    • 其他中东和非洲地区

第 16 章 竞争格局

  • 概述
  • 市占率分析
  • 主要公司的定位
  • 衝突领导地图
  • 供应商基准测试
  • 对标发展策略

第 17 章 公司简介

  • Incyte
  • BeiGene
  • MacroGenics
  • Adaptimmune Therapeutics
  • Immunomedics
  • Kite Pharma
  • Juno Therapeutics
  • Immunocore
  • Bluebird Bio
  • Celldex Therapeutics
  • OncoMed Pharmaceuticals
  • Argenx
  • Cellectis
  • Fate Therapeutics
  • Gritstone Oncology
  • Adaptimmune
  • Allogene Therapeutics
  • Iovance Biotherapeutics
  • Zymeworks
  • Compugen
简介目录
Product Code: GIS24892

The immunotherapy drugs market is estimated to expand from $163 billion in 2023 to $375 billion by 2033, with a compound annual growth rate (CAGR) of 8.5%.

The Immunotherapy Drugs Market encompasses the industry dedicated to developing and commercializing therapeutic agents that harness and enhance the body's immune system to combat diseases, notably cancer and autoimmune disorders. This market includes monoclonal antibodies, checkpoint inhibitors, vaccines, and cell therapies, representing a paradigm shift towards personalized medicine and offering promising avenues for improved patient outcomes and innovative treatment modalities.

The market is witnessing growth, primarily driven by advancements in cancer treatment and autoimmune disease management. Monoclonal antibodies lead the market, owing to their targeted action and efficacy in treating various cancers. Checkpoint inhibitors are the second highest performing sub-segment, gaining traction due to their ability to unleash the body's immune response against tumors. The North American region dominates the market, supported by strong healthcare infrastructure and significant R&D investments. Europe follows closely, bolstered by favorable government policies and increased adoption of novel therapies. Within these regions, the United States and Germany are the top-performing countries, reflecting their commitment to innovation and access to advanced healthcare solutions. The Asia-Pacific region is emerging as a lucrative market, driven by increasing healthcare expenditure and a growing patient population, particularly in China and India. These insights underscore the dynamic nature of the immunotherapy drugs market and the promising opportunities it presents.

In 2023, the Immunotherapy Drugs Market demonstrated robust growth, with the market volume reaching 320 million units. The monoclonal antibodies segment holds the largest market share at 45%, followed by immune checkpoint inhibitors at 30%, and cancer vaccines at 25%. This distribution reflects the increasing adoption of targeted therapies and the rising incidence of cancer worldwide. The monoclonal antibodies segment is particularly driven by advancements in biotechnology and personalized medicine.

The competitive landscape is dominated by key players such as Roche, Merck & Co., and Bristol-Myers Squibb, each leveraging strategic partnerships and innovative R&D to enhance their market positions. Regulatory influences, including FDA approvals and patent laws, significantly impact market dynamics. The market is poised for expansion, with opportunities in emerging markets and the development of novel immunotherapeutic agents. However, challenges such as high treatment costs and stringent regulatory requirements persist. The integration of artificial intelligence in drug development is expected to further propel growth.

North America dominates the immunotherapy drugs market, primarily driven by the United States. The region benefits from a robust healthcare infrastructure and significant investment in research and development. The presence of leading pharmaceutical companies and a strong focus on innovation further bolster this market. The high prevalence of chronic diseases in the region also fuels demand for advanced treatment options.

Europe holds a substantial share in the immunotherapy drugs market, with Germany, France, and the United Kingdom being key contributors. The region's well-established healthcare system and strong regulatory framework support market growth. European countries are also investing in personalized medicine, which enhances the adoption of immunotherapy drugs. The emphasis on cancer research and treatment innovation is a driving force in this region.

Asia Pacific is experiencing rapid growth in the immunotherapy drugs market. Rising healthcare expenditures and increasing awareness about advanced treatments contribute to this expansion. Countries like China and India are investing in healthcare infrastructure and research initiatives. The growing prevalence of cancer and other chronic diseases in these countries increases the demand for effective immunotherapy treatments.

Latin America and the Middle East & Africa regions are gradually emerging in the immunotherapy drugs market. Although these regions currently hold a smaller market share, increasing healthcare investments and improving access to advanced medical treatments are expected to drive growth. Governments in these regions are focusing on enhancing healthcare facilities and promoting research to support market development.

Key Companies

Incyte, Bei Gene, Macro Genics, Adaptimmune Therapeutics, Immunomedics, Kite Pharma, Juno Therapeutics, Immunocore, Bluebird Bio, Celldex Therapeutics, Onco Med Pharmaceuticals, Argenx, Cellectis, Fate Therapeutics, Gritstone Oncology, Adaptimmune, Allogene Therapeutics, Iovance Biotherapeutics, Zymeworks, Compugen

Sources

World Health Organization (WHO), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institutes of Health (NIH), American Association for Cancer Research (AACR), International Agency for Research on Cancer (IARC), Centers for Disease Control and Prevention (CDC), World Cancer Research Fund International, International Society for Biological Therapy of Cancer (iSBTc), Cancer Research UK, National Cancer Institute (NCI), European Society for Medical Oncology (ESMO), Society for Immunotherapy of Cancer (SITC), National Comprehensive Cancer Network (NCCN), American Society of Clinical Oncology (ASCO), Australian Therapeutic Goods Administration (TGA), Canadian Agency for Drugs and Technologies in Health (CADTH), International Conference on Cancer Immunotherapy, International Immunocompromised Host Society (ICHS), International Cancer Immunotherapy Conference (CICON).

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Immunotherapy Drugs Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Immunotherapy Drugs Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Application
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Process
  • 2.9 Key Highlights of the Market, by Mode
  • 2.10 Key Highlights of the Market, by Stage
  • 2.11 Key Highlights of the Market, by North America
  • 2.12 Key Highlights of the Market, by Europe
  • 2.13 Key Highlights of the Market, by Asia-Pacific
  • 2.14 Key Highlights of the Market, by Latin America
  • 2.15 Key Highlights of the Market, by Middle East
  • 2.16 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Application
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Process
  • 3.8 Market Attractiveness Analysis, by Mode
  • 3.9 Market Attractiveness Analysis, by Stage
  • 3.10 Market Attractiveness Analysis, by North America
  • 3.11 Market Attractiveness Analysis, by Europe
  • 3.12 Market Attractiveness Analysis, by Asia-Pacific
  • 3.13 Market Attractiveness Analysis, by Latin America
  • 3.14 Market Attractiveness Analysis, by Middle East
  • 3.15 Market Attractiveness Analysis, by Africa

4: Immunotherapy Drugs Market Outlook

  • 4.1 Immunotherapy Drugs Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Immunotherapy Drugs Immunotherapy Drugs Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Immunotherapy Drugs Market Size

  • 6.1 Immunotherapy Drugs Market Size, by Value
  • 6.2 Immunotherapy Drugs Market Size, by Volume

7: Immunotherapy Drugs Market, by Type

  • 7.1 Market Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Checkpoint Inhibitors
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Cytokines
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Cancer Vaccines
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Adoptive Cell Therapy
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Oncolytic Virus Therapy
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Others
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region

8: Immunotherapy Drugs Market, by Product

  • 8.1 Market Overview
  • 8.2 Therapeutic Vaccines
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Immune Checkpoint Inhibitors
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Non-specific Immunotherapies
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Oncolytic Virus Immunotherapy
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 CAR-T Cell Therapy
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Others
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region

9: Immunotherapy Drugs Market, by Application

  • 9.1 Market Overview
  • 9.2 Cancer
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Autoimmune Diseases
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Infectious Diseases
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Inflammatory Diseases
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Immunotherapy Drugs Market, by Technology

  • 10.1 Market Overview
  • 10.2 Gene Editing
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 CRISPR
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 RNA Interference
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Nanotechnology
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Recombinant DNA Technology
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Immunotherapy Drugs Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Clinics
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Research Institutes
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Biopharmaceutical Companies
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Immunotherapy Drugs Market, by Process

  • 12.1 Market Overview
  • 12.2 Manufacturing
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Research and Development
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Clinical Trials
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Regulatory Approval
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Commercialization
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: Immunotherapy Drugs Market, by Mode

  • 13.1 Market Overview
  • 13.2 Intravenous
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Oral
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Topical
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Inhalation
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: Immunotherapy Drugs Market, by Stage

  • 14.1 Market Overview
  • 14.2 Discovery
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Preclinical
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Clinical
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Approval
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Launch
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region
  • 14.7 Post-market Surveillance
    • 14.7.1 Key Market Trends & Opportunity Analysis
    • 14.7.2 Market Size and Forecast, by Region
  • 14.8 Others
    • 14.8.1 Key Market Trends & Opportunity Analysis
    • 14.8.2 Market Size and Forecast, by Region

15: Immunotherapy Drugs Market, by Region

  • 15.1 Overview
  • 15.2 North America
    • 15.2.1 Key Market Trends and Opportunities
    • 15.2.2 North America Market Size and Forecast, by Type
    • 15.2.3 North America Market Size and Forecast, by Product
    • 15.2.4 North America Market Size and Forecast, by Application
    • 15.2.5 North America Market Size and Forecast, by Technology
    • 15.2.6 North America Market Size and Forecast, by End User
    • 15.2.7 North America Market Size and Forecast, by Process
    • 15.2.8 North America Market Size and Forecast, by Mode
    • 15.2.9 North America Market Size and Forecast, by Stage
    • 15.2.10 North America Market Size and Forecast, by Country
    • 15.2.11 United States
      • 15.2.9.1 United States Market Size and Forecast, by Type
      • 15.2.9.2 United States Market Size and Forecast, by Product
      • 15.2.9.3 United States Market Size and Forecast, by Application
      • 15.2.9.4 United States Market Size and Forecast, by Technology
      • 15.2.9.5 United States Market Size and Forecast, by End User
      • 15.2.9.6 United States Market Size and Forecast, by Process
      • 15.2.9.7 United States Market Size and Forecast, by Mode
      • 15.2.9.8 United States Market Size and Forecast, by Stage
      • 15.2.9.9 Local Competition Analysis
      • 15.2.9.10 Local Market Analysis
    • 15.2.1 Canada
      • 15.2.10.1 Canada Market Size and Forecast, by Type
      • 15.2.10.2 Canada Market Size and Forecast, by Product
      • 15.2.10.3 Canada Market Size and Forecast, by Application
      • 15.2.10.4 Canada Market Size and Forecast, by Technology
      • 15.2.10.5 Canada Market Size and Forecast, by End User
      • 15.2.10.6 Canada Market Size and Forecast, by Process
      • 15.2.10.7 Canada Market Size and Forecast, by Mode
      • 15.2.10.8 Canada Market Size and Forecast, by Stage
      • 15.2.10.9 Local Competition Analysis
      • 15.2.10.10 Local Market Analysis
  • 15.1 Europe
    • 15.3.1 Key Market Trends and Opportunities
    • 15.3.2 Europe Market Size and Forecast, by Type
    • 15.3.3 Europe Market Size and Forecast, by Product
    • 15.3.4 Europe Market Size and Forecast, by Application
    • 15.3.5 Europe Market Size and Forecast, by Technology
    • 15.3.6 Europe Market Size and Forecast, by End User
    • 15.3.7 Europe Market Size and Forecast, by Process
    • 15.3.8 Europe Market Size and Forecast, by Mode
    • 15.3.9 Europe Market Size and Forecast, by Stage
    • 15.3.10 Europe Market Size and Forecast, by Country
    • 15.3.11 United Kingdom
      • 15.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 15.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 15.3.9.3 United Kingdom Market Size and Forecast, by Application
      • 15.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 15.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 15.3.9.6 United Kingdom Market Size and Forecast, by Process
      • 15.3.9.7 United Kingdom Market Size and Forecast, by Mode
      • 15.3.9.8 United Kingdom Market Size and Forecast, by Stage
      • 15.3.9.9 Local Competition Analysis
      • 15.3.9.10 Local Market Analysis
    • 15.3.1 Germany
      • 15.3.10.1 Germany Market Size and Forecast, by Type
      • 15.3.10.2 Germany Market Size and Forecast, by Product
      • 15.3.10.3 Germany Market Size and Forecast, by Application
      • 15.3.10.4 Germany Market Size and Forecast, by Technology
      • 15.3.10.5 Germany Market Size and Forecast, by End User
      • 15.3.10.6 Germany Market Size and Forecast, by Process
      • 15.3.10.7 Germany Market Size and Forecast, by Mode
      • 15.3.10.8 Germany Market Size and Forecast, by Stage
      • 15.3.10.9 Local Competition Analysis
      • 15.3.10.10 Local Market Analysis
    • 15.3.1 France
      • 15.3.11.1 France Market Size and Forecast, by Type
      • 15.3.11.2 France Market Size and Forecast, by Product
      • 15.3.11.3 France Market Size and Forecast, by Application
      • 15.3.11.4 France Market Size and Forecast, by Technology
      • 15.3.11.5 France Market Size and Forecast, by End User
      • 15.3.11.6 France Market Size and Forecast, by Process
      • 15.3.11.7 France Market Size and Forecast, by Mode
      • 15.3.11.8 France Market Size and Forecast, by Stage
      • 15.3.11.9 Local Competition Analysis
      • 15.3.11.10 Local Market Analysis
    • 15.3.1 Spain
      • 15.3.12.1 Spain Market Size and Forecast, by Type
      • 15.3.12.2 Spain Market Size and Forecast, by Product
      • 15.3.12.3 Spain Market Size and Forecast, by Application
      • 15.3.12.4 Spain Market Size and Forecast, by Technology
      • 15.3.12.5 Spain Market Size and Forecast, by End User
      • 15.3.12.6 Spain Market Size and Forecast, by Process
      • 15.3.12.7 Spain Market Size and Forecast, by Mode
      • 15.3.12.8 Spain Market Size and Forecast, by Stage
      • 15.3.12.9 Local Competition Analysis
      • 15.3.12.10 Local Market Analysis
    • 15.3.1 Italy
      • 15.3.13.1 Italy Market Size and Forecast, by Type
      • 15.3.13.2 Italy Market Size and Forecast, by Product
      • 15.3.13.3 Italy Market Size and Forecast, by Application
      • 15.3.13.4 Italy Market Size and Forecast, by Technology
      • 15.3.13.5 Italy Market Size and Forecast, by End User
      • 15.3.13.6 Italy Market Size and Forecast, by Process
      • 15.3.13.7 Italy Market Size and Forecast, by Mode
      • 15.3.13.8 Italy Market Size and Forecast, by Stage
      • 15.3.13.9 Local Competition Analysis
      • 15.3.13.10 Local Market Analysis
    • 15.3.1 Netherlands
      • 15.3.14.1 Netherlands Market Size and Forecast, by Type
      • 15.3.14.2 Netherlands Market Size and Forecast, by Product
      • 15.3.14.3 Netherlands Market Size and Forecast, by Application
      • 15.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 15.3.14.5 Netherlands Market Size and Forecast, by End User
      • 15.3.14.6 Netherlands Market Size and Forecast, by Process
      • 15.3.14.7 Netherlands Market Size and Forecast, by Mode
      • 15.3.14.8 Netherlands Market Size and Forecast, by Stage
      • 15.3.14.9 Local Competition Analysis
      • 15.3.14.10 Local Market Analysis
    • 15.3.1 Sweden
      • 15.3.15.1 Sweden Market Size and Forecast, by Type
      • 15.3.15.2 Sweden Market Size and Forecast, by Product
      • 15.3.15.3 Sweden Market Size and Forecast, by Application
      • 15.3.15.4 Sweden Market Size and Forecast, by Technology
      • 15.3.15.5 Sweden Market Size and Forecast, by End User
      • 15.3.15.6 Sweden Market Size and Forecast, by Process
      • 15.3.15.7 Sweden Market Size and Forecast, by Mode
      • 15.3.15.8 Sweden Market Size and Forecast, by Stage
      • 15.3.15.9 Local Competition Analysis
      • 15.3.15.10 Local Market Analysis
    • 15.3.1 Switzerland
      • 15.3.16.1 Switzerland Market Size and Forecast, by Type
      • 15.3.16.2 Switzerland Market Size and Forecast, by Product
      • 15.3.16.3 Switzerland Market Size and Forecast, by Application
      • 15.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 15.3.16.5 Switzerland Market Size and Forecast, by End User
      • 15.3.16.6 Switzerland Market Size and Forecast, by Process
      • 15.3.16.7 Switzerland Market Size and Forecast, by Mode
      • 15.3.16.8 Switzerland Market Size and Forecast, by Stage
      • 15.3.16.9 Local Competition Analysis
      • 15.3.16.10 Local Market Analysis
    • 15.3.1 Denmark
      • 15.3.17.1 Denmark Market Size and Forecast, by Type
      • 15.3.17.2 Denmark Market Size and Forecast, by Product
      • 15.3.17.3 Denmark Market Size and Forecast, by Application
      • 15.3.17.4 Denmark Market Size and Forecast, by Technology
      • 15.3.17.5 Denmark Market Size and Forecast, by End User
      • 15.3.17.6 Denmark Market Size and Forecast, by Process
      • 15.3.17.7 Denmark Market Size and Forecast, by Mode
      • 15.3.17.8 Denmark Market Size and Forecast, by Stage
      • 15.3.17.9 Local Competition Analysis
      • 15.3.17.10 Local Market Analysis
    • 15.3.1 Finland
      • 15.3.18.1 Finland Market Size and Forecast, by Type
      • 15.3.18.2 Finland Market Size and Forecast, by Product
      • 15.3.18.3 Finland Market Size and Forecast, by Application
      • 15.3.18.4 Finland Market Size and Forecast, by Technology
      • 15.3.18.5 Finland Market Size and Forecast, by End User
      • 15.3.18.6 Finland Market Size and Forecast, by Process
      • 15.3.18.7 Finland Market Size and Forecast, by Mode
      • 15.3.18.8 Finland Market Size and Forecast, by Stage
      • 15.3.18.9 Local Competition Analysis
      • 15.3.18.10 Local Market Analysis
    • 15.3.1 Russia
      • 15.3.19.1 Russia Market Size and Forecast, by Type
      • 15.3.19.2 Russia Market Size and Forecast, by Product
      • 15.3.19.3 Russia Market Size and Forecast, by Application
      • 15.3.19.4 Russia Market Size and Forecast, by Technology
      • 15.3.19.5 Russia Market Size and Forecast, by End User
      • 15.3.19.6 Russia Market Size and Forecast, by Process
      • 15.3.19.7 Russia Market Size and Forecast, by Mode
      • 15.3.19.8 Russia Market Size and Forecast, by Stage
      • 15.3.19.9 Local Competition Analysis
      • 15.3.19.10 Local Market Analysis
    • 15.3.1 Rest of Europe
      • 15.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 15.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 15.3.20.3 Rest of Europe Market Size and Forecast, by Application
      • 15.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 15.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 15.3.20.6 Rest of Europe Market Size and Forecast, by Process
      • 15.3.20.7 Rest of Europe Market Size and Forecast, by Mode
      • 15.3.20.8 Rest of Europe Market Size and Forecast, by Stage
      • 15.3.20.9 Local Competition Analysis
      • 15.3.20.10 Local Market Analysis
  • 15.1 Asia-Pacific
    • 15.4.1 Key Market Trends and Opportunities
    • 15.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 15.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 15.4.4 Asia-Pacific Market Size and Forecast, by Application
    • 15.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 15.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 15.4.7 Asia-Pacific Market Size and Forecast, by Process
    • 15.4.8 Asia-Pacific Market Size and Forecast, by Mode
    • 15.4.9 Asia-Pacific Market Size and Forecast, by Stage
    • 15.4.10 Asia-Pacific Market Size and Forecast, by Country
    • 15.4.11 China
      • 15.4.9.1 China Market Size and Forecast, by Type
      • 15.4.9.2 China Market Size and Forecast, by Product
      • 15.4.9.3 China Market Size and Forecast, by Application
      • 15.4.9.4 China Market Size and Forecast, by Technology
      • 15.4.9.5 China Market Size and Forecast, by End User
      • 15.4.9.6 China Market Size and Forecast, by Process
      • 15.4.9.7 China Market Size and Forecast, by Mode
      • 15.4.9.8 China Market Size and Forecast, by Stage
      • 15.4.9.9 Local Competition Analysis
      • 15.4.9.10 Local Market Analysis
    • 15.4.1 India
      • 15.4.10.1 India Market Size and Forecast, by Type
      • 15.4.10.2 India Market Size and Forecast, by Product
      • 15.4.10.3 India Market Size and Forecast, by Application
      • 15.4.10.4 India Market Size and Forecast, by Technology
      • 15.4.10.5 India Market Size and Forecast, by End User
      • 15.4.10.6 India Market Size and Forecast, by Process
      • 15.4.10.7 India Market Size and Forecast, by Mode
      • 15.4.10.8 India Market Size and Forecast, by Stage
      • 15.4.10.9 Local Competition Analysis
      • 15.4.10.10 Local Market Analysis
    • 15.4.1 Japan
      • 15.4.11.1 Japan Market Size and Forecast, by Type
      • 15.4.11.2 Japan Market Size and Forecast, by Product
      • 15.4.11.3 Japan Market Size and Forecast, by Application
      • 15.4.11.4 Japan Market Size and Forecast, by Technology
      • 15.4.11.5 Japan Market Size and Forecast, by End User
      • 15.4.11.6 Japan Market Size and Forecast, by Process
      • 15.4.11.7 Japan Market Size and Forecast, by Mode
      • 15.4.11.8 Japan Market Size and Forecast, by Stage
      • 15.4.11.9 Local Competition Analysis
      • 15.4.11.10 Local Market Analysis
    • 15.4.1 South Korea
      • 15.4.12.1 South Korea Market Size and Forecast, by Type
      • 15.4.12.2 South Korea Market Size and Forecast, by Product
      • 15.4.12.3 South Korea Market Size and Forecast, by Application
      • 15.4.12.4 South Korea Market Size and Forecast, by Technology
      • 15.4.12.5 South Korea Market Size and Forecast, by End User
      • 15.4.12.6 South Korea Market Size and Forecast, by Process
      • 15.4.12.7 South Korea Market Size and Forecast, by Mode
      • 15.4.12.8 South Korea Market Size and Forecast, by Stage
      • 15.4.12.9 Local Competition Analysis
      • 15.4.12.10 Local Market Analysis
    • 15.4.1 Australia
      • 15.4.13.1 Australia Market Size and Forecast, by Type
      • 15.4.13.2 Australia Market Size and Forecast, by Product
      • 15.4.13.3 Australia Market Size and Forecast, by Application
      • 15.4.13.4 Australia Market Size and Forecast, by Technology
      • 15.4.13.5 Australia Market Size and Forecast, by End User
      • 15.4.13.6 Australia Market Size and Forecast, by Process
      • 15.4.13.7 Australia Market Size and Forecast, by Mode
      • 15.4.13.8 Australia Market Size and Forecast, by Stage
      • 15.4.13.9 Local Competition Analysis
      • 15.4.13.10 Local Market Analysis
    • 15.4.1 Singapore
      • 15.4.14.1 Singapore Market Size and Forecast, by Type
      • 15.4.14.2 Singapore Market Size and Forecast, by Product
      • 15.4.14.3 Singapore Market Size and Forecast, by Application
      • 15.4.14.4 Singapore Market Size and Forecast, by Technology
      • 15.4.14.5 Singapore Market Size and Forecast, by End User
      • 15.4.14.6 Singapore Market Size and Forecast, by Process
      • 15.4.14.7 Singapore Market Size and Forecast, by Mode
      • 15.4.14.8 Singapore Market Size and Forecast, by Stage
      • 15.4.14.9 Local Competition Analysis
      • 15.4.14.10 Local Market Analysis
    • 15.4.1 Indonesia
      • 15.4.15.1 Indonesia Market Size and Forecast, by Type
      • 15.4.15.2 Indonesia Market Size and Forecast, by Product
      • 15.4.15.3 Indonesia Market Size and Forecast, by Application
      • 15.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 15.4.15.5 Indonesia Market Size and Forecast, by End User
      • 15.4.15.6 Indonesia Market Size and Forecast, by Process
      • 15.4.15.7 Indonesia Market Size and Forecast, by Mode
      • 15.4.15.8 Indonesia Market Size and Forecast, by Stage
      • 15.4.15.9 Local Competition Analysis
      • 15.4.15.10 Local Market Analysis
    • 15.4.1 Taiwan
      • 15.4.16.1 Taiwan Market Size and Forecast, by Type
      • 15.4.16.2 Taiwan Market Size and Forecast, by Product
      • 15.4.16.3 Taiwan Market Size and Forecast, by Application
      • 15.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 15.4.16.5 Taiwan Market Size and Forecast, by End User
      • 15.4.16.6 Taiwan Market Size and Forecast, by Process
      • 15.4.16.7 Taiwan Market Size and Forecast, by Mode
      • 15.4.16.8 Taiwan Market Size and Forecast, by Stage
      • 15.4.16.9 Local Competition Analysis
      • 15.4.16.10 Local Market Analysis
    • 15.4.1 Malaysia
      • 15.4.17.1 Malaysia Market Size and Forecast, by Type
      • 15.4.17.2 Malaysia Market Size and Forecast, by Product
      • 15.4.17.3 Malaysia Market Size and Forecast, by Application
      • 15.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 15.4.17.5 Malaysia Market Size and Forecast, by End User
      • 15.4.17.6 Malaysia Market Size and Forecast, by Process
      • 15.4.17.7 Malaysia Market Size and Forecast, by Mode
      • 15.4.17.8 Malaysia Market Size and Forecast, by Stage
      • 15.4.17.9 Local Competition Analysis
      • 15.4.17.10 Local Market Analysis
    • 15.4.1 Rest of Asia-Pacific
      • 15.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 15.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 15.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 15.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 15.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 15.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 15.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 15.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 15.4.18.9 Local Competition Analysis
      • 15.4.18.10 Local Market Analysis
  • 15.1 Latin America
    • 15.5.1 Key Market Trends and Opportunities
    • 15.5.2 Latin America Market Size and Forecast, by Type
    • 15.5.3 Latin America Market Size and Forecast, by Product
    • 15.5.4 Latin America Market Size and Forecast, by Application
    • 15.5.5 Latin America Market Size and Forecast, by Technology
    • 15.5.6 Latin America Market Size and Forecast, by End User
    • 15.5.7 Latin America Market Size and Forecast, by Process
    • 15.5.8 Latin America Market Size and Forecast, by Mode
    • 15.5.9 Latin America Market Size and Forecast, by Stage
    • 15.5.10 Latin America Market Size and Forecast, by Country
    • 15.5.11 Brazil
      • 15.5.9.1 Brazil Market Size and Forecast, by Type
      • 15.5.9.2 Brazil Market Size and Forecast, by Product
      • 15.5.9.3 Brazil Market Size and Forecast, by Application
      • 15.5.9.4 Brazil Market Size and Forecast, by Technology
      • 15.5.9.5 Brazil Market Size and Forecast, by End User
      • 15.5.9.6 Brazil Market Size and Forecast, by Process
      • 15.5.9.7 Brazil Market Size and Forecast, by Mode
      • 15.5.9.8 Brazil Market Size and Forecast, by Stage
      • 15.5.9.9 Local Competition Analysis
      • 15.5.9.10 Local Market Analysis
    • 15.5.1 Mexico
      • 15.5.10.1 Mexico Market Size and Forecast, by Type
      • 15.5.10.2 Mexico Market Size and Forecast, by Product
      • 15.5.10.3 Mexico Market Size and Forecast, by Application
      • 15.5.10.4 Mexico Market Size and Forecast, by Technology
      • 15.5.10.5 Mexico Market Size and Forecast, by End User
      • 15.5.10.6 Mexico Market Size and Forecast, by Process
      • 15.5.10.7 Mexico Market Size and Forecast, by Mode
      • 15.5.10.8 Mexico Market Size and Forecast, by Stage
      • 15.5.10.9 Local Competition Analysis
      • 15.5.10.10 Local Market Analysis
    • 15.5.1 Argentina
      • 15.5.11.1 Argentina Market Size and Forecast, by Type
      • 15.5.11.2 Argentina Market Size and Forecast, by Product
      • 15.5.11.3 Argentina Market Size and Forecast, by Application
      • 15.5.11.4 Argentina Market Size and Forecast, by Technology
      • 15.5.11.5 Argentina Market Size and Forecast, by End User
      • 15.5.11.6 Argentina Market Size and Forecast, by Process
      • 15.5.11.7 Argentina Market Size and Forecast, by Mode
      • 15.5.11.8 Argentina Market Size and Forecast, by Stage
      • 15.5.11.9 Local Competition Analysis
      • 15.5.11.10 Local Market Analysis
    • 15.5.1 Rest of Latin America
      • 15.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 15.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 15.5.12.3 Rest of Latin America Market Size and Forecast, by Application
      • 15.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 15.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 15.5.12.6 Rest of Latin America Market Size and Forecast, by Process
      • 15.5.12.7 Rest of Latin America Market Size and Forecast, by Mode
      • 15.5.12.8 Rest of Latin America Market Size and Forecast, by Stage
      • 15.5.12.9 Local Competition Analysis
      • 15.5.12.10 Local Market Analysis
  • 15.1 Middle East and Africa
    • 15.6.1 Key Market Trends and Opportunities
    • 15.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 15.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 15.6.4 Middle East and Africa Market Size and Forecast, by Application
    • 15.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 15.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 15.6.7 Middle East and Africa Market Size and Forecast, by Process
    • 15.6.8 Middle East and Africa Market Size and Forecast, by Mode
    • 15.6.9 Middle East and Africa Market Size and Forecast, by Stage
    • 15.6.10 Middle East and Africa Market Size and Forecast, by Country
    • 15.6.11 Saudi Arabia
      • 15.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 15.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 15.6.9.3 Saudi Arabia Market Size and Forecast, by Application
      • 15.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 15.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 15.6.9.6 Saudi Arabia Market Size and Forecast, by Process
      • 15.6.9.7 Saudi Arabia Market Size and Forecast, by Mode
      • 15.6.9.8 Saudi Arabia Market Size and Forecast, by Stage
      • 15.6.9.9 Local Competition Analysis
      • 15.6.9.10 Local Market Analysis
    • 15.6.1 UAE
      • 15.6.10.1 UAE Market Size and Forecast, by Type
      • 15.6.10.2 UAE Market Size and Forecast, by Product
      • 15.6.10.3 UAE Market Size and Forecast, by Application
      • 15.6.10.4 UAE Market Size and Forecast, by Technology
      • 15.6.10.5 UAE Market Size and Forecast, by End User
      • 15.6.10.6 UAE Market Size and Forecast, by Process
      • 15.6.10.7 UAE Market Size and Forecast, by Mode
      • 15.6.10.8 UAE Market Size and Forecast, by Stage
      • 15.6.10.9 Local Competition Analysis
      • 15.6.10.10 Local Market Analysis
    • 15.6.1 South Africa
      • 15.6.11.1 South Africa Market Size and Forecast, by Type
      • 15.6.11.2 South Africa Market Size and Forecast, by Product
      • 15.6.11.3 South Africa Market Size and Forecast, by Application
      • 15.6.11.4 South Africa Market Size and Forecast, by Technology
      • 15.6.11.5 South Africa Market Size and Forecast, by End User
      • 15.6.11.6 South Africa Market Size and Forecast, by Process
      • 15.6.11.7 South Africa Market Size and Forecast, by Mode
      • 15.6.11.8 South Africa Market Size and Forecast, by Stage
      • 15.6.11.9 Local Competition Analysis
      • 15.6.11.10 Local Market Analysis
    • 15.6.1 Rest of MEA
      • 15.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 15.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 15.6.12.3 Rest of MEA Market Size and Forecast, by Application
      • 15.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 15.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 15.6.12.6 Rest of MEA Market Size and Forecast, by Process
      • 15.6.12.7 Rest of MEA Market Size and Forecast, by Mode
      • 15.6.12.8 Rest of MEA Market Size and Forecast, by Stage
      • 15.6.12.9 Local Competition Analysis
      • 15.6.12.10 Local Market Analysis

16: Competitive Landscape

  • 16.1 Overview
  • 16.2 Market Share Analysis
  • 16.3 Key Player Positioning
  • 16.4 Competitive Leadership Mapping
    • 16.4.1 Star Players
    • 16.4.2 Innovators
    • 16.4.3 Emerging Players
  • 16.5 Vendor Benchmarking
  • 16.6 Developmental Strategy Benchmarking
    • 16.6.1 New Product Developments
    • 16.6.2 Product Launches
    • 16.6.3 Business Expansions
    • 16.6.4 Partnerships, Joint Ventures, and Collaborations
    • 16.6.5 Mergers and Acquisitions

17: Company Profiles

  • 17.1 Incyte
    • 17.1.1 Company Overview
    • 17.1.2 Company Snapshot
    • 17.1.3 Business Segments
    • 17.1.4 Business Performance
    • 17.1.5 Product Offerings
    • 17.1.6 Key Developmental Strategies
    • 17.1.7 SWOT Analysis
  • 17.2 BeiGene
    • 17.2.1 Company Overview
    • 17.2.2 Company Snapshot
    • 17.2.3 Business Segments
    • 17.2.4 Business Performance
    • 17.2.5 Product Offerings
    • 17.2.6 Key Developmental Strategies
    • 17.2.7 SWOT Analysis
  • 17.3 MacroGenics
    • 17.3.1 Company Overview
    • 17.3.2 Company Snapshot
    • 17.3.3 Business Segments
    • 17.3.4 Business Performance
    • 17.3.5 Product Offerings
    • 17.3.6 Key Developmental Strategies
    • 17.3.7 SWOT Analysis
  • 17.4 Adaptimmune Therapeutics
    • 17.4.1 Company Overview
    • 17.4.2 Company Snapshot
    • 17.4.3 Business Segments
    • 17.4.4 Business Performance
    • 17.4.5 Product Offerings
    • 17.4.6 Key Developmental Strategies
    • 17.4.7 SWOT Analysis
  • 17.5 Immunomedics
    • 17.5.1 Company Overview
    • 17.5.2 Company Snapshot
    • 17.5.3 Business Segments
    • 17.5.4 Business Performance
    • 17.5.5 Product Offerings
    • 17.5.6 Key Developmental Strategies
    • 17.5.7 SWOT Analysis
  • 17.6 Kite Pharma
    • 17.6.1 Company Overview
    • 17.6.2 Company Snapshot
    • 17.6.3 Business Segments
    • 17.6.4 Business Performance
    • 17.6.5 Product Offerings
    • 17.6.6 Key Developmental Strategies
    • 17.6.7 SWOT Analysis
  • 17.7 Juno Therapeutics
    • 17.7.1 Company Overview
    • 17.7.2 Company Snapshot
    • 17.7.3 Business Segments
    • 17.7.4 Business Performance
    • 17.7.5 Product Offerings
    • 17.7.6 Key Developmental Strategies
    • 17.7.7 SWOT Analysis
  • 17.8 Immunocore
    • 17.8.1 Company Overview
    • 17.8.2 Company Snapshot
    • 17.8.3 Business Segments
    • 17.8.4 Business Performance
    • 17.8.5 Product Offerings
    • 17.8.6 Key Developmental Strategies
    • 17.8.7 SWOT Analysis
  • 17.9 Bluebird Bio
    • 17.9.1 Company Overview
    • 17.9.2 Company Snapshot
    • 17.9.3 Business Segments
    • 17.9.4 Business Performance
    • 17.9.5 Product Offerings
    • 17.9.6 Key Developmental Strategies
    • 17.9.7 SWOT Analysis
  • 17.10 Celldex Therapeutics
    • 17.10.1 Company Overview
    • 17.10.2 Company Snapshot
    • 17.10.3 Business Segments
    • 17.10.4 Business Performance
    • 17.10.5 Product Offerings
    • 17.10.6 Key Developmental Strategies
    • 17.10.7 SWOT Analysis
  • 17.11 OncoMed Pharmaceuticals
    • 17.11.1 Company Overview
    • 17.11.2 Company Snapshot
    • 17.11.3 Business Segments
    • 17.11.4 Business Performance
    • 17.11.5 Product Offerings
    • 17.11.6 Key Developmental Strategies
    • 17.11.7 SWOT Analysis
  • 17.12 Argenx
    • 17.12.1 Company Overview
    • 17.12.2 Company Snapshot
    • 17.12.3 Business Segments
    • 17.12.4 Business Performance
    • 17.12.5 Product Offerings
    • 17.12.6 Key Developmental Strategies
    • 17.12.7 SWOT Analysis
  • 17.13 Cellectis
    • 17.13.1 Company Overview
    • 17.13.2 Company Snapshot
    • 17.13.3 Business Segments
    • 17.13.4 Business Performance
    • 17.13.5 Product Offerings
    • 17.13.6 Key Developmental Strategies
    • 17.13.7 SWOT Analysis
  • 17.14 Fate Therapeutics
    • 17.14.1 Company Overview
    • 17.14.2 Company Snapshot
    • 17.14.3 Business Segments
    • 17.14.4 Business Performance
    • 17.14.5 Product Offerings
    • 17.14.6 Key Developmental Strategies
    • 17.14.7 SWOT Analysis
  • 17.15 Gritstone Oncology
    • 17.15.1 Company Overview
    • 17.15.2 Company Snapshot
    • 17.15.3 Business Segments
    • 17.15.4 Business Performance
    • 17.15.5 Product Offerings
    • 17.15.6 Key Developmental Strategies
    • 17.15.7 SWOT Analysis
  • 17.16 Adaptimmune
    • 17.16.1 Company Overview
    • 17.16.2 Company Snapshot
    • 17.16.3 Business Segments
    • 17.16.4 Business Performance
    • 17.16.5 Product Offerings
    • 17.16.6 Key Developmental Strategies
    • 17.16.7 SWOT Analysis
  • 17.17 Allogene Therapeutics
    • 17.17.1 Company Overview
    • 17.17.2 Company Snapshot
    • 17.17.3 Business Segments
    • 17.17.4 Business Performance
    • 17.17.5 Product Offerings
    • 17.17.6 Key Developmental Strategies
    • 17.17.7 SWOT Analysis
  • 17.18 Iovance Biotherapeutics
    • 17.18.1 Company Overview
    • 17.18.2 Company Snapshot
    • 17.18.3 Business Segments
    • 17.18.4 Business Performance
    • 17.18.5 Product Offerings
    • 17.18.6 Key Developmental Strategies
    • 17.18.7 SWOT Analysis
  • 17.19 Zymeworks
    • 17.19.1 Company Overview
    • 17.19.2 Company Snapshot
    • 17.19.3 Business Segments
    • 17.19.4 Business Performance
    • 17.19.5 Product Offerings
    • 17.19.6 Key Developmental Strategies
    • 17.19.7 SWOT Analysis
  • 17.20 Compugen
    • 17.20.1 Company Overview
    • 17.20.2 Company Snapshot
    • 17.20.3 Business Segments
    • 17.20.4 Business Performance
    • 17.20.5 Product Offerings
    • 17.20.6 Key Developmental Strategies
    • 17.20.7 SWOT Analysis